These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19398663)

  • 1. Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.
    Wang X; Chow FL; Oka T; Hao L; Lopez-Campistrous A; Kelly S; Cooper S; Odenbach J; Finegan BA; Schulz R; Kassiri Z; Lopaschuk GD; Fernandez-Patron C
    Circulation; 2009 May; 119(18):2480-9. PubMed ID: 19398663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis.
    Wang X; Oka T; Chow FL; Cooper SB; Odenbach J; Lopaschuk GD; Kassiri Z; Fernandez-Patron C
    Hypertension; 2009 Sep; 54(3):575-82. PubMed ID: 19581512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.
    Odenbach J; Wang X; Cooper S; Chow FL; Oka T; Lopaschuk G; Kassiri Z; Fernandez-Patron C
    Hypertension; 2011 Jan; 57(1):123-30. PubMed ID: 21079048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats.
    Nagareddy PR; MacLeod KM; McNeill JH
    Cardiovasc Res; 2010 Jul; 87(1):177-86. PubMed ID: 20110336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway.
    Hao L; Du M; Lopez-Campistrous A; Fernandez-Patron C
    Circ Res; 2004 Jan; 94(1):68-76. PubMed ID: 14656925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nitric oxide synthase deficiency on a disintegrin and metalloproteinase domain-containing protein 12 expression in mouse brain samples.
    Lendeckel U; Wolke C; Bernstein HG; Keilhoff G
    Mol Med Rep; 2015 Aug; 12(2):2253-62. PubMed ID: 25892053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
    Asakura M; Kitakaze M; Takashima S; Liao Y; Ishikura F; Yoshinaka T; Ohmoto H; Node K; Yoshino K; Ishiguro H; Asanuma H; Sanada S; Matsumura Y; Takeda H; Beppu S; Tada M; Hori M; Higashiyama S
    Nat Med; 2002 Jan; 8(1):35-40. PubMed ID: 11786904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease.
    Berry E; Bosonea AM; Wang X; Fernandez-Patron C
    J Vasc Res; 2013; 50(1):52-68. PubMed ID: 23172306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha--converting enzyme roles in hypertension-induced hypertrophy: look both ways when crossing the street.
    Zamilpa R; Chilton RJ; Lindsey ML
    Hypertension; 2009 Sep; 54(3):471-2. PubMed ID: 19581499
    [No Abstract]   [Full Text] [Related]  

  • 10. Transactivated EGFR mediates α₁-AR-induced STAT3 activation and cardiac hypertrophy.
    Li Y; Zhang H; Liao W; Song Y; Ma X; Chen C; Lu Z; Li Z; Zhang Y
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1941-51. PubMed ID: 21856923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature.
    Keys JR; Greene EA; Koch WJ; Eckhart AD
    Hypertension; 2002 Nov; 40(5):660-6. PubMed ID: 12411459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive coupling of a naturally occurring human alpha1a-adrenergic receptor genetic variant to EGFR transactivation pathway.
    Oganesian A; Yarov-Yarovoy V; Parks WC; Schwinn DA
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19796-801. PubMed ID: 22089237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Nox4 promotes angiotensin II-induced epidermal growth factor receptor activation and subsequent cardiac hypertrophy by increasing ADAM17 expression.
    Zeng SY; Chen X; Chen SR; Li Q; Wang YH; Zou J; Cao WW; Luo JN; Gao H; Liu PQ
    Can J Cardiol; 2013 Oct; 29(10):1310-9. PubMed ID: 23850346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.
    Rodrigues SF; Tran ED; Fortes ZB; Schmid-Schönbein GW
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H25-35. PubMed ID: 20382857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-(1-7) ameliorates myocardial remodeling and interstitial fibrosis in spontaneous hypertension: role of MMPs/TIMPs.
    Pei Z; Meng R; Li G; Yan G; Xu C; Zhuang Z; Ren J; Wu Z
    Toxicol Lett; 2010 Nov; 199(2):173-81. PubMed ID: 20837116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular smooth muscle polyploidy and cardiac hypertrophy in genetic hypertension.
    Dominiczak AF; Devlin AM; Lee WK; Anderson NH; Bohr DF; Reid JL
    Hypertension; 1996 Mar; 27(3 Pt 2):752-9. PubMed ID: 8613236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy.
    Huang CY; Kuo CH; Pai PY; Ho TJ; Lin YM; Chen RJ; Tsai FJ; Vijaya Padma V; Kuo WW; Huang CY
    Int J Cardiol; 2018 Apr; 257():283-290. PubMed ID: 29180262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Disintegrin and Metalloprotease-22 Attenuates Hypertrophic Remodeling in Mice Through Inhibition of the Protein Kinase B Signaling Pathway.
    Ren L; Wu C; Yang K; Chen S; Ye P; Wu J; Zhang A; Huang X; Wang K; Deng P; Ding X; Chen M; Xia J
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29358191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1β-induced matrix metalloproteinase-13 is activated by a disintegrin and metalloprotease-28-regulated proliferation of human osteoblast-like cells.
    Ozeki N; Kawai R; Yamaguchi H; Hiyama T; Kinoshita K; Hase N; Nakata K; Kondo A; Mogi M; Nakamura H
    Exp Cell Res; 2014 Apr; 323(1):165-177. PubMed ID: 24613731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A disintegrin and metalloproteinase 12 prevents heart failure by regulating cardiac hypertrophy and fibrosis.
    Nakamura Y; Kita S; Tanaka Y; Fukuda S; Obata Y; Okita T; Kawachi Y; Tsugawa-Shimizu Y; Fujishima Y; Nishizawa H; Miyagawa S; Sawa Y; Sehara-Fujisawa A; Maeda N; Shimomura I
    Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H238-H251. PubMed ID: 31774689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.